BIOMAT Database Logo BIOMAT Database Logo

Weekly paclitaxel infusion in elderly patients with solid tumors. 2002

Lazzaro Repetto, and Maria Pietropaolo, and Roberta Granata, and Irene Ventura, and Walter Gianni
UO Oncologia INRCA, Rome.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females

Related Publications

Lazzaro Repetto, and Maria Pietropaolo, and Roberta Granata, and Irene Ventura, and Walter Gianni
Weekly 1 hour paclitaxel infusion in patients with recurrent gynecological tumors: a pilot study.
August 2001, Japanese journal of clinical oncology,
Lazzaro Repetto, and Maria Pietropaolo, and Roberta Granata, and Irene Ventura, and Walter Gianni
A feasibility study of 1-h paclitaxel infusion in patients with solid tumors.
January 1997, Cancer chemotherapy and pharmacology,
Lazzaro Repetto, and Maria Pietropaolo, and Roberta Granata, and Irene Ventura, and Walter Gianni
Phase I study of pazopanib in combination with weekly paclitaxel in patients with advanced solid tumors.
January 2010, The oncologist,
Lazzaro Repetto, and Maria Pietropaolo, and Roberta Granata, and Irene Ventura, and Walter Gianni
UFT/calcium folinate plus weekly paclitaxel for solid tumors.
July 1999, Oncology (Williston Park, N.Y.),
Lazzaro Repetto, and Maria Pietropaolo, and Roberta Granata, and Irene Ventura, and Walter Gianni
Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumors.
June 2007, Clinical cancer research : an official journal of the American Association for Cancer Research,
Lazzaro Repetto, and Maria Pietropaolo, and Roberta Granata, and Irene Ventura, and Walter Gianni
Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors.
December 2000, Cancer,
Lazzaro Repetto, and Maria Pietropaolo, and Roberta Granata, and Irene Ventura, and Walter Gianni
Phase I study of the farnesyltransferase inhibitor lonafarnib with weekly paclitaxel in patients with solid tumors.
January 2007, Clinical cancer research : an official journal of the American Association for Cancer Research,
Lazzaro Repetto, and Maria Pietropaolo, and Roberta Granata, and Irene Ventura, and Walter Gianni
A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors.
August 2001, American journal of clinical oncology,
Lazzaro Repetto, and Maria Pietropaolo, and Roberta Granata, and Irene Ventura, and Walter Gianni
UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumors.
October 2000, Oncology (Williston Park, N.Y.),
Lazzaro Repetto, and Maria Pietropaolo, and Roberta Granata, and Irene Ventura, and Walter Gianni
Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors.
February 2010, Annals of oncology : official journal of the European Society for Medical Oncology,
Copied contents to your clipboard!